Franklin FTSE South Korea ETF vs Roivant Sciences Ltd. Common Shares — how do they compare? Franklin FTSE South Korea ETF trades at $58.12 (market cap $1.88B), while Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $25.09B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 13.3× Franklin FTSE South Korea ETF's market cap, and Franklin FTSE South Korea ETF is more actively traded (709,775 versus 5,738,571). Which is the better fit depends on your goals — on Pluang, investors hold Franklin FTSE South Korea ETF for 15 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| FLKR | ROIV | |
|---|---|---|
Market Cap | $1.88B | $25.09B |
Volume | 709,775 | 5,738,571 |
Sector | Broad Market / Factor | Health |
52-Week High | $72.25 | $41.81 |
52-Week Low | $27.09 | $16.04 |
Typical Hold Time | 15 Days | 0 Days |
Enterprise Value | — | $21.36B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Franklin FTSE South Korea ETF seeks to track an index of South Korean equities. The fund provides exposure to companies listed in South Korea across multiple sectors.
Read more on FLKR →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →